Phospho-Histone H4 (Ser47) Antibody

What is Phospho-Histone H4 (Ser47) and what is its primary biological function?

Phospho-Histone H4 (Ser47) refers to histone H4 that has been phosphorylated at serine 47, a specific post-translational modification. This phosphorylation plays a crucial role in regulating nucleosome assembly pathways. Specifically, H4S47ph promotes the assembly of the histone variant H3.3-H4 into nucleosomes by the histone chaperone HIRA, while simultaneously inhibiting the assembly of H3.1-H4 by the CAF-1 chaperone .

Histone H4 is a core component of nucleosomes, which wrap and compact DNA into chromatin. This compaction limits DNA accessibility to cellular machinery that requires DNA as a template. Through post-translational modifications like phosphorylation at Ser47, histone H4 participates in the dynamic regulation of transcription, DNA repair, DNA replication, and chromosomal stability .

The functional significance of H4S47ph lies in its ability to distinctly regulate different histone variant assembly pathways. H3.3 differs from canonical H3.1 by only five amino acids but has unique functions in transcriptionally active regions that cannot be substituted by H3.1 . By influencing which histone variant is assembled into nucleosomes, H4S47ph contributes to epigenetic regulation of gene expression.

Which enzyme is responsible for phosphorylating Histone H4 at Ser47?

The phosphorylation of histone H4 at Ser47 is catalyzed by p21-protein-activated kinase 2 (PAK2) . PAK2 is a member of the p21-activated serine/threonine kinase family. Research has demonstrated that PAK2 specifically targets Ser47 on histone H4, and this phosphorylation event is regulated through a complex interplay of kinases and phosphatases.

PAK2 itself is activated through phosphorylation at Ser141 . Additionally, phosphatases including PP1α, PP1β, and Wip1 regulate P-Ser47-Histone H4 levels through activation or deactivation of PAK2 . Depletion of PP1α and PP1β has been shown to result in increased PAK2 phosphorylation at Ser141, which subsequently affects H4S47ph levels .

In vitro and in vivo studies have confirmed the role of PAK2 in this specific phosphorylation. When PAK2 is depleted in cells using shRNA techniques, there is a significant reduction in H4S47ph levels as detected by both immunofluorescence and Western blot analyses . Furthermore, PAK2, but not the kinase-dead (KD) mutant of PAK2, has been shown to bind to histones H3 and H4 in vivo, supporting its direct role in H4 phosphorylation .

What are the optimal methods for detecting Phospho-Histone H4 (Ser47) in experimental samples?

Several methodologies have been validated for detecting Phospho-Histone H4 (Ser47) in experimental samples, each with specific advantages depending on research requirements:

Western Blot Analysis:
Western blot represents a primary method for detecting and quantifying H4S47ph. Specific antibodies against P-Ser47-Histone H4 can detect the phosphorylated form in cell or tissue lysates. The recommended dilution range for Western blot applications is typically 1:500-2000 . For optimal results, researchers should extract nuclear fractions, as histones are predominantly nuclear proteins. When developing the blots, high-sensitivity chemiluminescence reagents (such as Femto Chemiluminescence) are recommended for P-Ser47-Histone H4 detection .

Immunofluorescence/Immunocytochemistry:
For visualizing the cellular localization of H4S47ph, immunofluorescence represents an excellent approach. The recommended antibody dilution for immunofluorescence applications ranges from 1:200-1:1000 . This technique allows researchers to observe the nuclear localization pattern of H4S47ph and has been successfully applied to various cell types including HUVEC and neuronal cells .

Mass Spectrometry:
For definitive identification and quantification of H4S47ph, mass spectrometry provides the highest specificity. In studies comparing different cell lines (such as B103 vs. B103-695 cells), liquid chromatography-tandem mass spectrometry (LC-MS/MS) has successfully identified and quantified this modification . The extracted ion chromatogram (XIC) allows for relative quantification by comparing peak areas, while MS/MS spectra provide sequence confirmation of the phosphorylated peptide.

ELISA:
For high-throughput quantitative analysis, ELISA can be employed with recommended antibody dilutions around 1:5000 .

Importantly, validation of phospho-specific antibodies should include appropriate controls such as:

• Phosphatase treatment of samples (should eliminate signal)

• Mutation of Ser47 (e.g., to glutamate in recombinant proteins)

• Phosphopeptide competition assays to confirm specificity

How can researchers ensure specificity when detecting Phospho-Histone H4 (Ser47) versus other histone phosphorylation sites?

Ensuring specificity when detecting Phospho-Histone H4 (Ser47) requires multiple validation approaches to distinguish it from other histone phosphorylation sites:

Antibody Validation Procedures:

• Phosphopeptide competition assays: This critical validation method involves pre-incubating the phospho-specific antibody with phosphopeptides containing the phosphorylated Ser47 epitope before immunodetection. As demonstrated in immunofluorescence analyses of HUVEC cells, signal disappears in the presence of the specific phosphopeptide . This confirms antibody specificity for the phosphorylated epitope.

• Phosphatase treatment: Samples treated with phosphatase should show significant signal reduction or elimination when probed with H4S47ph antibodies. Studies have confirmed that phosphatase treatment of 293T cell extracts eliminates H4S47ph detection, validating that the antibody specifically recognizes the phosphorylated form .

• Mutational analysis: Using recombinant H4 with Ser47 mutated to glutamate (H4S47E) provides another specificity control. Antibodies specific to H4S47ph recognize wild-type H4 but not the S47E mutant when expressed in cells .

Technical Considerations:

• Extraction protocols: Use nuclear extraction methods that preserve phosphorylation states by including phosphatase inhibitors in all buffers.

• Cross-reactivity assessment: Test the antibody against recombinant histones with various phosphorylation modifications to ensure it does not recognize similar epitopes.

• Specificity verification in multiple cell types: Validate antibody specificity across different cell lines to ensure consistent detection.

Orthogonal Detection Methods:
Researchers should employ at least two independent detection methods, such as Western blot and mass spectrometry, to confirm the specificity of H4S47ph detection. Mass spectrometry analysis can provide definitive identification of the phosphorylation site based on the peptide mass and fragmentation pattern .

How does Phospho-Histone H4 (Ser47) regulate differential nucleosome assembly of histone variants?

Phospho-Histone H4 (Ser47) plays a sophisticated role in differentially regulating nucleosome assembly pathways for distinct histone H3 variants through the following mechanisms:

Differential Binding Affinity Regulation:
H4S47ph modulates the binding interactions between histone chaperones and their corresponding H3-H4 substrates. Specifically:

• Enhanced HIRA-H3.3-H4 Interaction: Phosphorylation of H4 at Ser47 significantly increases the binding affinity of the histone chaperone HIRA to H3.3-H4 complexes. In vitro immunoprecipitation experiments have demonstrated that H4S47ph substantially enhances HIRA's association with H3.3-H4 tetramers in the presence of ATP (required for phosphorylation) .

• Reduced CAF-1-H3.1-H4 Interaction: Conversely, the same modification reduces the binding affinity of the CAF-1 chaperone complex to H3.1-H4 tetramers. When H4 is phosphorylated at Ser47, significantly less CAF-1 (detected by both p150 and p60 subunits) copurifies with the modified H4 .

In Vivo Evidence:
Experimental manipulations that alter H4S47ph levels demonstrate consistent effects on chaperone-histone interactions:

• When cells are treated with okadaic acid (OA), a phosphatase inhibitor that increases H4S47ph levels, more HIRA and less CAF-1 copurify with histone H4 .

• Conversely, in PAK2-depleted cells (where H4S47ph is reduced), substantially less H3-H4 copurifies with HIRA and significantly more H3-H4 associates with CAF-1 .

Two-Step Model for Differential Assembly:
Based on these findings, researchers have proposed a step-wise model to explain how H4S47ph regulates nucleosome assembly:

• First, the specific amino acid differences between H3.1 and H3.3 (positions 87, 89, and 91) facilitate initial recognition by their respective chaperones (CAF-1 for H3.1 and HIRA for H3.3).

• Subsequently, H4S47ph acts as a regulatory switch that:

  • Further enhances HIRA binding to H3.3-H4, promoting assembly of H3.3-H4S47ph into nucleosomes

  • Prevents CAF-1 from binding to H3.1-H4S47ph, inhibiting assembly of these complexes into nucleosomes

This dual regulatory mechanism ensures proper deposition of histone variants at appropriate genomic locations, with H3.3 typically associated with actively transcribed regions and H3.1 with replication-coupled assembly.

What is known about the temporal dynamics of H4S47 phosphorylation during the cell cycle?

While the search results don't provide explicit information about the temporal dynamics of H4S47 phosphorylation throughout the cell cycle, several insights can be derived from the available data:

Association with Newly Synthesized Histones:
H4S47ph has been detected on histones associated with Asf1a and Asf1b, which are histone chaperones that bind newly synthesized histones and function in both replication-coupled (RC) and replication-independent (RI) nucleosome assembly . This suggests that H4S47 phosphorylation may occur early in the histone life cycle, potentially during or shortly after histone synthesis.

Relationship to Nucleosome Assembly Pathways:
The involvement of H4S47ph in regulating both replication-coupled (H3.1 deposition via CAF-1) and replication-independent (H3.3 deposition via HIRA) nucleosome assembly pathways provides indirect evidence about its potential temporal regulation:

• Replication-Coupled Assembly: Since H4S47ph inhibits CAF-1-mediated assembly of H3.1-H4, its levels might be regulated during S-phase when replication-coupled nucleosome assembly is most active. Lower H4S47ph levels during replication would permit CAF-1-mediated assembly.

• Replication-Independent Assembly: The enhancement of HIRA-mediated assembly of H3.3-H4 by H4S47ph suggests this modification might be more prevalent during phases of the cell cycle when transcription-coupled histone exchange is occurring, potentially throughout G1, G2, and even during S-phase at transcriptionally active regions.

Regulatory Enzymes:
The kinase responsible for H4S47 phosphorylation, PAK2, is known to be regulated by various signaling pathways. PAK2 itself is activated by phosphorylation at Ser141 , and its activity may vary throughout the cell cycle in response to cellular signaling events.

Additionally, the phosphatases that regulate H4S47ph levels (PP1α, PP1β, and Wip1) might show cell cycle-dependent activity, potentially leading to cyclical patterns of H4S47 phosphorylation.

Further research specifically examining the levels of H4S47ph at different cell cycle stages would be necessary to establish a definitive temporal profile of this modification during the cell cycle.

What is the evidence linking Phospho-Histone H4 (Ser47) to Alzheimer's disease pathology?

Several lines of evidence from cellular and human studies suggest a significant connection between Phospho-Histone H4 (Ser47) and Alzheimer's disease (AD) pathology:

Cellular Models of AD:

• APP-expressing cells: B103-695 cells (expressing amyloid precursor protein) showed a statistically significant 1.89-fold increase in phosphoSer47-Histone H4 compared to control B103 cells. This finding was established through both phosphoproteomics analysis and western blot validation of nuclear fractions .

• Aβ-treated primary neurons: When primary cortical neurons were treated with 5μM oligomeric Aβ42 for 24 hours, they exhibited a significant increase in phosphorylation of Histone H4 at Ser47, while total Histone H4 levels remained unchanged . This provides direct evidence that Aβ, a key pathological protein in AD, can induce H4S47 phosphorylation.

Human AD Brain Samples:
Analysis of brain tissue from patients at different stages of disease progression revealed a progressive increase in H4S47 phosphorylation:

• Mild Cognitive Impairment (MCI): Brain samples from MCI patients showed slightly enhanced phosphorylation of Histone H4 at Ser47 compared to non-AD (NAD) controls .

• Late Alzheimer's Disease (LAD): Brain samples from LAD patients exhibited significantly increased levels of P-Histone H4-Ser47 compared to NAD controls . These LAD samples were validated to contain elevated levels of Aβ (detected by 6E10 antibody) and hyperphosphorylated tau (detected by PHF-1 antibody targeting Ser396/Ser404 phosphorylation) .

Disease Progression Correlation:
The observed pattern of H4S47ph levels correlating with disease progression (NAD < MCI < LAD) suggests this histone modification may be linked to the advancement of AD pathology . The researchers concluded that "phosphorylation of Histone H4 at Ser47 is a disease-specific modification and this might have implications in advancement of pathology development in AD" .

Potential Mechanistic Link:
While the exact mechanism connecting H4S47ph to AD pathology remains to be fully elucidated, the researchers suggest this modification may influence gene expression patterns. Since H3.3 (whose deposition is enhanced by H4S47ph) is localized to gene bodies of actively transcribed genes and positively correlates with gene expression , altered H4S47 phosphorylation could potentially impact transcriptional profiles relevant to AD progression.

These findings collectively suggest that Phospho-Histone H4 (Ser47) may represent a novel epigenetic marker associated with AD pathology and could potentially serve as a target for understanding disease mechanisms or therapeutic development.

How might aberrant regulation of H4S47 phosphorylation contribute to disease states beyond Alzheimer's?

While the search results primarily focus on Alzheimer's disease in relation to H4S47 phosphorylation, the fundamental roles of this modification in nucleosome assembly and chromatin regulation suggest potential implications for various other disease states:

Cancer Implications:
Given that PAK2 (the kinase responsible for H4S47 phosphorylation) is involved in various signaling pathways and that dysregulation of histone modifications is a hallmark of many cancers, aberrant H4S47 phosphorylation could potentially contribute to oncogenic processes through:

• Altered Transcriptional Programs: Since H4S47ph influences the deposition of H3.3, which is associated with actively transcribed genes , dysregulation could lead to inappropriate gene expression patterns characteristic of cancer cells.

• Genomic Instability: Proper nucleosome assembly is critical for maintaining genomic stability during DNA replication and repair. Disruption of the balance between H3.1 and H3.3 deposition pathways due to abnormal H4S47 phosphorylation could potentially contribute to genomic instability, a hallmark of cancer.

• Cell Cycle Regulation: PAK2 activity is regulated in response to various signaling events, and its dysregulation could affect cell cycle progression through altered chromatin states.

Neurodevelopmental Disorders:
Proper chromatin regulation is essential during neurodevelopment, and disruptions in histone modifications have been implicated in various neurodevelopmental disorders:

• Altered Neuronal Gene Expression: Since H4S47ph affects nucleosome assembly pathways, its dysregulation could potentially impact neurodevelopmental gene expression programs.

• Synaptic Plasticity: Chromatin remodeling and histone modifications play important roles in synaptic plasticity and memory formation. Aberrant H4S47 phosphorylation could potentially affect these processes.

Inflammatory Conditions:
PAK2 can be activated by various signaling pathways, including those involved in inflammation. Dysregulation of H4S47 phosphorylation might therefore be involved in inflammatory conditions through:

• Altered Expression of Inflammatory Genes: Changes in nucleosome assembly patterns could affect the expression of genes involved in inflammatory responses.

• Cellular Stress Responses: Chromatin remodeling is an important aspect of cellular stress responses, and disruptions in this process due to abnormal H4S47 phosphorylation could potentially affect how cells respond to inflammatory stressors.

It's important to note that these potential connections are largely speculative based on the known functions of H4S47 phosphorylation in nucleosome assembly and would require specific studies to establish definitive links to these disease states.

How can researchers manipulate H4S47 phosphorylation levels to study its functional consequences?

Researchers can employ several sophisticated approaches to manipulate H4S47 phosphorylation levels and investigate its functional consequences:

Genetic Manipulation Strategies:

• PAK2 Modulation:

  • Depletion: RNA interference (shRNA or siRNA) targeting PAK2 has been successfully used to reduce H4S47ph levels. Multiple shRNA constructs against PAK2 have demonstrated significant reduction in H4S47ph as detected by both immunofluorescence and Western blot .

  • Overexpression: Conversely, overexpression of wild-type PAK2 (but not kinase-dead mutants) can increase H4S47ph levels.

  • Kinase-dead mutants: Expression of catalytically inactive PAK2 can potentially function as a dominant-negative inhibitor of endogenous PAK2 activity .

• Histone H4 Mutants:

  • Non-phosphorylatable mutants: Engineering H4 with Ser47 mutated to alanine (S47A) prevents phosphorylation.

  • Phosphomimetic mutants: H4 with Ser47 mutated to glutamate (S47E) mimics constitutive phosphorylation. This approach has been validated in studies showing that H4S47E behaves similarly to phosphorylated H4 in terms of differential binding to histone chaperones .

Pharmacological Approaches:

• Phosphatase Inhibitors:

  • Okadaic acid (OA) treatment significantly increases H4S47ph levels by inhibiting protein phosphatases that normally regulate this modification . This approach has been demonstrated to increase the association of HIRA with H4 and decrease CAF-1 association, consistent with the effects of H4S47 phosphorylation .

• PAK2 Inhibitors:

  • Small molecule inhibitors targeting PAK kinases could potentially be used to reduce H4S47 phosphorylation, though specific efficacy would need to be validated.

Experimental Readouts:

Following manipulation of H4S47 phosphorylation levels, researchers can assess functional consequences through several approaches:

• Chromatin Immunoprecipitation (ChIP):

  • Analyze genome-wide distribution of histone variants (H3.1 vs. H3.3) to determine how H4S47ph affects their deposition patterns.

  • Combine with sequencing (ChIP-seq) to identify specific genomic regions affected.

• Interaction Studies:

  • Immunoprecipitation followed by Western blot to assess changes in interactions between histones and their chaperones (HIRA, CAF-1) .

  • In vitro binding assays using recombinant proteins to directly measure binding affinities under different phosphorylation conditions .

• Transcriptional Analysis:

  • RNA-seq to determine how alterations in H4S47ph affect gene expression profiles.

  • This is particularly relevant given H3.3's association with actively transcribed genes .

• Cellular Phenotypes:

  • In neuronal models, assess impacts on synaptic plasticity, morphology, or survival, especially in the context of neurodegeneration models .

  • In dividing cells, examine effects on cell cycle progression, DNA damage responses, or chromosome segregation.

What are the most promising future research directions for understanding the role of Phospho-Histone H4 (Ser47) in chromatin biology?

Several promising research directions would significantly advance our understanding of Phospho-Histone H4 (Ser47) in chromatin biology:

Single-Cell and Spatial Chromatin Analysis:

• Single-cell epigenomics: Applying single-cell technologies to study H4S47ph distribution would reveal cell-to-cell variability in this modification and potentially identify distinct cellular subpopulations with different H4S47ph levels and corresponding functional states.

• Spatial chromatin organization: Investigating how H4S47ph affects three-dimensional chromatin architecture using techniques like Hi-C or ChIA-PET could reveal its role in organizing higher-order chromatin structures and enhancer-promoter interactions.

Dynamic Regulation Studies:

• Cell cycle-specific regulation: Developing live-cell imaging approaches with phospho-specific biosensors could enable real-time monitoring of H4S47ph dynamics throughout the cell cycle and during cellular differentiation.

• Stimulus-responsive changes: Examining how external stimuli (growth factors, stress, etc.) affect H4S47ph levels would provide insight into its role in cellular adaptation. This is particularly relevant given that PAK2 is activated by various signaling pathways.

Integrative Multi-omics Approaches:

• Combined ChIP-seq and RNA-seq: Correlating genome-wide H4S47ph distribution with transcriptional changes upon manipulation of this modification would help establish direct links between H4S47ph and gene expression.

• Proteogenomic integration: Combining H4S47ph ChIP-seq with proteomics to identify proteins preferentially recruited to or excluded from chromatin regions with this modification would reveal downstream effectors.

Neurodegenerative Disease Mechanisms:

• Temporal analysis in disease progression: Examining H4S47ph changes during different stages of neurodegeneration in animal models could establish whether alterations in this modification precede or follow pathological hallmarks.

• Cell type-specific effects: Investigating whether H4S47ph changes in AD affect specific neuronal or glial populations differently would provide insight into selective cellular vulnerability.

• Therapeutic targeting: Exploring whether normalization of H4S47ph levels can mitigate disease phenotypes in cellular or animal models of neurodegeneration. The observed increase in H4S47ph in AD brain samples suggests this might be a promising therapeutic target.

Evolutionary Conservation and Divergence:

• Comparative studies across species: Examining the conservation of H4S47ph and its regulatory mechanisms across different organisms would reveal its evolutionary importance and potentially identify model systems for mechanistic studies.

• Variant-specific functions: Further investigating how H4S47ph differentially affects various H3 variants beyond H3.1 and H3.3 (such as centromeric H3 variants) would provide a more comprehensive understanding of its role in chromatin specialization.

These research directions would significantly expand our understanding of how H4S47ph contributes to the dynamic regulation of chromatin structure and function in both normal cellular processes and disease states.